Livagen is a synthetic tetrapeptide bioregulator investigated for its potential to impact aging tissues by inhibiting peptidases and modulating gene expression. Educational protocols suggest a daily subcutaneous dose ranging from 500 mcg to 2 mg, gradually increasing over an 8-12 week cycle. It is reconstituted with bacteriostatic water for administration.
- Synthetic tetrapeptide bioregulator.
- Dosage typically ranges from 0.5-2.0 mg daily, titrated over weeks.
- Reconstitute 20 mg vial with 3.0 mL of bacteriostatic water.
- Administered via once-daily subcutaneous injection.
- May influence enkephalin-degrading enzymes and gene expression.
Reconstitution
Vial strength
20 mg
Bacteriostatic water
3 mL
Concentration
6.67 mg/mL
1 unit = 0.01 mL = 66.7 mcg
- 1Draw 3.0 mL of bacteriostatic water into a sterile syringe.
- 2Slowly inject the water down the interior wall of the Livagen vial, being careful to avoid frothing.
- 3Gently swirl or roll the vial until the powder is fully dissolved; do not shake.
- 4Label the reconstituted vial with the date and refrigerate it at 2–8 °C (35.6–46.4 °F), protected from light.
Dosing schedule
| Phase | Dose | On a U-100 syringe |
|---|---|---|
| Weeks 1–2 | 0.5 mg (500 mcg) | 7.5 units (0.075 mL) |
| Weeks 3–4 | 1.0 mg (1000 mcg) | 15 units (0.15 mL) |
| Weeks 5–6 | 1.5 mg (1500 mcg) | 22.5 units (0.225 mL) |
| Weeks 7–12 | 2.0 mg (2000 mcg) | 30 units (0.30 mL) |
Protocol detail
| Start | Begin with 0.5 mg daily; increase the dose by approximately 0.5 mg every 1–2 weeks if tolerated. |
|---|---|
| Target | Aim for a daily dose of 1.5–2.0 mg by Weeks 5–12. |
| Frequency | Administer once per day via subcutaneous injection. |
| Cycle Length | Typically 8–12 weeks, with an optional extension to 16 weeks. |
| Timing | Inject at a consistent time each day; remember to rotate injection sites. |
Overview at a glance
| Goal | Support cellular homeostasis and regenerative processes in aging tissues. |
|---|---|
| Schedule | Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired). |
| Dose Range | 0.5–2.0 mg daily with gradual titration. |
| Reconstitution | 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements. |
| Storage | Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw. |
How it works
Livagen functions through two primary mechanisms: peptidase inhibition and epigenetic modulation. It effectively inhibits enkephalin-degrading enzymes in human serum, potentially prolonging the activity of natural enkephalins without directly binding to opioid receptors. Furthermore, in aged cells, Livagen has been observed to induce heterochromatin decondensation and reactivate specific ribosomal genes. Preclinical studies suggest it may enhance cellular structure and regenerative processes and could normalize digestive enzyme activities in aged animals, shifting them towards more youthful patterns.
Reported effects
- Potential inhibition of enkephalin-degrading enzymes, extending endogenous enkephalin signaling.
- May modulate gene expression and chromatin architecture in aging tissues.
- Preclinical data suggests support for cellular homeostasis and regenerative capacity.
- Observed normalization of digestive enzyme activity in aged rodents.
Reported side effects
- No human clinical administration studies; human side effect profile is unknown.
- Possible mild injection-site reactions (e.g., redness, itching) with subcutaneous administration.
Storage
Lyophilised (unmixed)
Store at -20 °C (-4 °F) in dry, dark conditions; minimize moisture exposure.
After reconstitution
Refrigerate at 2-8 °C (35.6-46.4 °F); avoid freeze-thaw cycles. Protect from light.
Supplies
| Peptide vials (Livagen, 20 mg each) | Approximately 4 vials for 8 weeks, 7 for 12 weeks, and 10 for 16 weeks |
|---|---|
| Insulin Syringes (U-100) | 7 syringes per week (56 for 8 weeks, 84 for 12 weeks, 112 for 16 weeks) |
| Bacteriostatic Water (10 mL bottles) | Estimate 2x10 mL bottles for 8-12 weeks, 3x10 mL bottles for 16 weeks |
| Alcohol Swabs | Approx. 2 per day (112 for 8 weeks, 168 for 12 weeks, 224 for 16 weeks) |
Important notes
- Always use new, sterile insulin syringes and dispose of them in a sharps container.
- Rotate injection sites (e.g., abdomen, thighs, upper arms) to prevent local irritation.
- Inject slowly and pause for a few seconds before withdrawing the needle.
- Accurately document daily doses and injection site rotation for consistency.
- Livagen dosing is based on preclinical data and analogous peptide bioregulators due to a lack of human clinical trials.
Frequently asked questions
How does Livagen compare to other anti-aging compounds?
Livagen is a synthetic tetrapeptide bioregulator, which means it's a small peptide that is thought to interact with biological processes at a cellular level, particularly concerning aging. Its proposed mechanisms involve inhibiting specific enzymes and modulating gene expression, setting it apart from broader antioxidants or hormone therapies. It is considered a bioregulator, a class of peptides believed to restore natural biological functions.
Are there any specific dietary or lifestyle recommendations while using Livagen?
While no specific dietary restrictions are mandated, maintaining an overall healthy lifestyle is always beneficial. This includes a balanced, nutrient-rich diet to support cellular health, regular physical activity to enhance metabolic and regenerative adaptations, and prioritizing quality sleep and stress reduction to promote general homeostasis and potentially amplify any benefits from the peptide.
Can Livagen be taken orally or does it always require injection?
The educational protocols for Livagen specify subcutaneous injection. Peptides often have poor bioavailability when taken orally due to degradation by digestive enzymes. While some preclinical studies in rats mentioned oral administration for Livagen, for research purposes based on existing protocols, subcutaneous injection is the recommended route to ensure proper absorption and efficacy.
What should I do if I miss a dose of Livagen?
If you miss a dose, it is generally recommended to take it as soon as you remember, unless it is close to the time for your next scheduled dose. In that case, it is best to skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one. Consistency is key, so try to adhere to your daily timing as much as possible.
Educational reference only. These figures summarise how Livagen is commonly described in research literature and supplier documentation, including the Livagen listing at peptidesuk4u.co.uk. They are not a prescription, not medical advice, and not a recommendation to self-administer anything.
Related protocols
FOXO4-DRI (10 mg Vial)
Targets senescent cells for anti-aging and tissue rejuvenation.
NAD+ (500 mg Vial)
Fuel cellular energy, enhance DNA repair, support mitochondrial health.
CJC-1295 DAC (2 mg Vial)
Long-acting GHRH analog for sustained growth hormone release.
CJC-1295 NO DAC (5 mg Vial)
Stimulates natural growth hormone release for improved body composition and recovery.